Independent · London · Published independently
Cosmetology London

A city guide to aesthetic medicine

The business of the market

London light-based advertising rules: ASA update

A dated reference to ASA and CAP material on ultraviolet tanning claims and the wider advertising questions for London light-based services.

Sources read18 November 2026
Enforcement Notice dated12 November 2026
Active monitoring begins after14 December 2026
Rulings cited9, from 2021 to 2026

The short answer

As read on 18 November 2026, the ASA says advertisers of sunbeds and tanning salons must not attribute health, vitamin D, medical or safety claims to sunbed use. Its active monitoring is due to begin after 14 December 2026. This page reports published ASA and CAP material only, not legal advice.

What changed for ultraviolet tanning advertising?

The ASA resource page headed Ads for sunbeds and tanning salons, dated 12 November 2026 and read on 18 November 2026, says that its Enforcement Notice gives guidance intended to help advertisers of sunbeds and tanning salons comply with the CAP Code. The resource page states that advertisers must not attribute health, vitamin D, medical or safety claims to sunbed use.

The operative date on that resource page is that active monitoring begins after 14 December 2026. The page says this will be followed by targeted enforcement action where needed. This is a published timing statement, not a prediction about any individual advertiser, premises or campaign.

The Enforcement Notice is presented by the ASA as a PDF alongside the resource page. That PDF was not read for this reference. Accordingly, this page does not summarise, interpret or add to its contents. The statements in this section come from the ASA resource page only, read on 18 November 2026.

This is the advertising companion to this publication's London clinic licence and registration index. The index concerns what an operator may need to hold or register against. This page concerns a separate question: the ASA and CAP material on what may be said in advertising. Neither page determines whether a particular activity needs a licence, registration or other approval.

The scope is deliberately narrow. It reports the regulator's published position on claims connected with ultraviolet tanning, then identifies the limited Code rules named in the supplied ASA material that are relevant when a clinic or salon considers advertising a light-based service. It does not assess services, outcomes, equipment, consumer suitability or compliance in a particular case.

What the ASA's February guidance says about claims

The ASA's CAP news explainer Keeping Sunbed Advertising on the Sunny Side of the Code, dated 26 February 2026 and read on 18 November 2026, says advertisements must not claim or imply that sunbed use is safe, harmless or without risk. It also says advertisers should avoid health or medical claims, whether explicit or implied, about the effects of ultraviolet tanning.

The distinction between an express statement and an implication matters to the regulator's published wording. A claim need not use a medical label to be treated as a health or medical claim. The ASA explainer does not, on the material read for this page, provide a universal wording test for every advertisement. This reference therefore does not attempt to decide which individual images, captions, testimonials, offers or social posts would amount to an implication.

The ASA's AdviceOnline page Beauty and Cosmetics: Sunbeds, dated 2 February 2026 and read on 18 November 2026, similarly says marketers should not claim or imply that use of such products is safe or without risk. It says that a marketer making a health-benefit claim should hold robust clinical evidence with trials performed on human subjects.

That AdviceOnline page further says that any reference to treating a condition for which medical supervision should be sought is very likely to be problematic. The conditions it names include psoriasis, seasonal affective disorder, depression, osteoporosis, Alzheimer's and eczema. This list is reported because it appears on the ASA page. It is not a statement by this publication about any condition, treatment or service.

Both the February explainer and the February AdviceOnline page pre-date the November Enforcement Notice resource page. The later page is the source for the 14 December 2026 monitoring timetable; the earlier pages provide the published explanatory context on safety, health and medical claims.

Which CAP Code rules are identified in the published material?

The ASA material supplied for this reference identifies several CAP Code rules by number. CAP rule 3.1 concerns misleading advertising. CAP rule 1.3 concerns social responsibility. In the material described here, rule 1.3 is cited where health-benefit claims were irresponsibly linked to ultraviolet use. CAP rule 12.2 states: Marketers must not discourage essential treatment for conditions for which medical supervision should be sought.

For an operator reading advertisements rather than a legal text, the practical boundary of this reference is important. The ASA's published material identifies these rules in relation to the claims at issue. This page does not offer a legal interpretation of how a rule applies to a proposed advertisement, and it does not state that any feature necessarily engages a particular rule.

CAP rule 12.25 and BCAP rule 32.2.9 are described in the supplied source material as 2021 rules barring the marketing of cosmetic interventions to under eighteens. Rule 12.25 therefore reaches beyond ultraviolet tanning in subject matter. It is relevant to the wider question of how cosmetic interventions are marketed, including the audience to which marketing is directed.

The source material does not enable this page to classify every light-based service as a cosmetic intervention, or to decide how the rules apply to any particular communication. No such classification is made here. Nor does this reference reproduce Code provisions beyond the wording of rule 12.2 quoted above.

CAP and the ASA have different published roles within the advertising system, but this page does not attempt to describe their institutional processes beyond what the cited ASA pages say. The useful retrieval point is narrower: claims about ultraviolet tanning can raise misleading advertising, social responsibility and medical-supervision questions in the regulator's published material.

What does this mean for advertising any light-based service?

The direct subject of the ASA pages read for this reference is sunbed use and ultraviolet tanning. A London clinic or salon advertising another light-based service should not treat this page as a finding that the sunbed material applies in the same way to that service. The published sources reviewed here do not provide a service-by-service map for all light-based advertising.

What the sources do establish is the nature of the questions that appear in the ultraviolet tanning material: whether an advertisement makes or implies a safety claim; whether it attributes a health, vitamin D or medical claim; whether a condition requiring medical supervision is invoked; whether a claim is misleading; and, where cosmetic interventions are concerned, whether marketing is directed at under eighteens. Those are questions reported from the named ASA and CAP material, not instructions from this publication.

This reference does not advise an operator what wording to use, remove, qualify or approve. It does not provide copy clearance, a compliance checklist or a substitute for reviewing the CAP Code and the relevant regulator material. It also does not say that a claim is acceptable merely because it is absent from the examples on the ASA pages.

The November 2026 ASA resource page expressly concerns advertisers of sunbeds and tanning salons. The February 2026 explainer discusses ultraviolet tanning. The February 2026 AdviceOnline page is headed for sunbeds. Where a reader wants to transfer a principle from those pages to a different light-based service, this page does not know whether that transfer is appropriate. That is a limit of the available, reviewed material.

No statement here addresses safety, protection, effectiveness, health outcomes, medical outcomes or consumer risk. Sun protection factor and sunscreen are outside the subject of this reference.

Why the 2026 notice has a documented enforcement background

The ASA material supplied for this page identifies rulings that preceded the November 2026 Enforcement Notice resource page. Four rulings dated 21 January 2026 carry the references A25-1306576, A25-1306585, A25-1306587 and A25-1306588. The supplied material describes them as concerning claims that the service was safe or healthy and claims concerning mood, energy, vitamin D, eczema, psoriasis and seasonal affective disorder.

Earlier rulings identified in the same material include A25-1286191, dated 17 September 2025, where studies cited as evidence were found insufficient; G24-1248081, dated 9 October 2024; A23-1198240 and A23-1198241, both dated 13 December 2023; and A20-1077067, dated 7 April 2021. The supplied material says the two December 2023 rulings also concerned targeting through TikTok.

These references and dates are included to show the published sequence described in the source brief: rulings came before the Enforcement Notice resource page. They are not a list of businesses, a directory, or a determination about any current advertiser. No business names are reproduced here.

The record also has an evidential point. The AdviceOnline page, read on 18 November 2026, says that a marketer claiming a health benefit should hold robust clinical evidence with trials performed on human subjects. The September 2025 ruling reference is included because the supplied source material says evidence cited there was insufficient. This reference does not evaluate studies, identify evidence standards beyond the ASA page's wording, or assess any present-day claim.

Dates matter because the November notice resource page gives a future monitoring threshold: after 14 December 2026. As at the read date of 18 November 2026, that monitoring start was still to come. The February guidance and the listed rulings were already past events on that date.

Screenshot rule: dates, sources and what is known

The table separates source dates, read dates and operative dates. It is designed so that a statement does not travel without its source and timing. "Not known from reviewed page" means this reference does not infer an answer from material that was not read or that did not state one.

ItemPublished dateRead dateWhat the reviewed source saysStatus on 18 November 2026
ASA resource page: Ads for sunbeds and tanning salons12 November 202618 November 2026No health, vitamin D, medical or safety claims attributed to sunbed use; active monitoring begins after 14 December 2026.Published; monitoring date still to come.
ASA CAP news explainer26 February 202618 November 2026No claim or implication that sunbed use is safe, harmless or without risk; avoid health or medical claims about ultraviolet tanning.Past publication.
ASA AdviceOnline: Beauty and Cosmetics: Sunbeds2 February 202618 November 2026Addresses safety implications, health-benefit evidence and references to conditions requiring medical supervision.Past publication.
Enforcement Notice PDFNot established from reviewed materialNot readNot summarised on this page.Its detailed contents are not known here.

Decision rule: where the reviewed ASA pages expressly concern ultraviolet tanning, report their wording as such. Where a reader asks whether the same position governs a different light-based service, this page does not decide. Where the PDF was not read, this page does not describe it.

Limits, status and the ASA's own disclaimer

This page is a dated reference, not legal advice. It reports the ASA and CAP material specified for review and does not speak for the ASA, CAP or any enforcement body. It does not tell an operator what it must say, may say, should say, remove or retain in advertising. It does not determine whether an advertisement complies with the CAP Code.

The ASA AdviceOnline page Beauty and Cosmetics: Sunbeds, read on 18 November 2026, carries the ASA's disclaimer that its advice does not constitute legal advice and does not bind CAP, the CAP advisory panels or the ASA. That disclaimer is repeated here because it is material to the status of the source itself.

This page applies only as a reference for readers seeking the regulator's published position as available on 18 November 2026. It is not a clinical reference, a safety assessment, a guide to health outcomes, an equipment guide, a licensing guide or a consumer treatment guide. It does not cover sunscreen or sun protection factor.

It also does not cover every advertising medium, every audience issue, every local authority requirement or every CAP Code provision. The appearance of social media in the supplied ruling history does not make this a social-media compliance guide. The companion London clinic licence and registration index remains the relevant publication page for the separate question of what an operator may need to hold or register against.

No clinic, salon, product, retailer, practitioner or venue is named. No service is recommended or assessed. The absence of a topic from this reference means only that it was outside the reviewed source material or deliberately outside scope.

Disclosure. This article names no business and carries no commercial link. Nobody paid for its publication.

How to check anything here
  1. Advertising Standards Authority, Enforcement Notice, Ads for sunbeds and tanning salons, dated 12 November 2026. www.asa.org.uk
  2. Committee of Advertising Practice news, Keeping Sunbed Advertising on the Sunny Side of the Code, dated 26 February 2026. www.asa.org.uk
  3. AdviceOnline, Beauty and Cosmetics: Sunbeds, dated 2 February 2026. www.asa.org.uk
  4. Care Quality Commission, find and check services. www.cqc.org.uk
  5. General Medical Council, the medical register. www.gmc-uk.org
  6. Joint Council for Cosmetic Practitioners, practitioner register. www.jccp.org.uk
  7. Save Face, the accredited register of practitioners and clinics. www.saveface.co.uk

Questions readers ask

When does ASA active monitoring begin?

The ASA resource page dated 12 November 2026, read on 18 November 2026, says active monitoring of advertisements for sunbeds and tanning salons begins after 14 December 2026. On the stated read date, that start point was still to come. The page says targeted enforcement action may follow where needed.

Does this page say a light-based service is safe or unsafe?

No. This reference makes no safety, protection, health, medical or outcome claim about any service. It reports that ASA material on ultraviolet tanning says advertisements must not claim or imply that sunbed use is safe, harmless or without risk. It does not extend that finding to other services.

What claims does the ASA resource page identify for sunbed advertising?

The ASA resource page dated 12 November 2026 says advertisers must not attribute health, vitamin D, medical or safety claims to sunbed use. This page reports that statement as published. It does not decide whether wording in a particular advert amounts to one of those claims or an implication.

Do the ultraviolet tanning rules automatically apply to every light-based service?

This reference does not make that conclusion. The reviewed ASA pages concern sunbeds and ultraviolet tanning. They do not provide a service-by-service account for every light-based treatment. The page identifies questions appearing in the source material, but does not classify services or interpret the Code for individual advertisements.

Which Code rules are relevant in the reviewed material?

The supplied ASA material identifies CAP rules 3.1, 1.3, 12.2 and 12.25, plus BCAP rule 32.2.9. Rule 12.2 says marketers must not discourage essential treatment for conditions for which medical supervision should be sought. This page does not provide an interpretation of those rules.

Was the Enforcement Notice PDF reviewed?

No. The ASA resource page linking to the Enforcement Notice was read on 18 November 2026, but the PDF itself was not read. This reference therefore does not summarise the PDF or rely on details said to appear only within it. That limitation is stated wherever the notice is discussed.

Is this legal advice or ASA copy clearance?

No. The ASA AdviceOnline page itself says its advice does not constitute legal advice and does not bind CAP, the CAP advisory panels or the ASA. This publication likewise gives no legal advice, copy approval or finding of compliance. It is a dated account of the reviewed regulator material.

The London list

Updates from the London market

We email when a district guide is updated, when guidance or regulation changes, and when something in the London market shifts what patients should be asking.

No clinic promotions, no treatment offers, no sponsored messages. One-click unsubscribe on every email.